|
|
Genotype and phenotype analysis of 15 rare β-thalassemia carriers in Guizhou Province |
WU Peng1 XIE Dan2 WU Jiangfen2 WANG Lei2 LI Di3 HUANG Shengwen1 |
1.School of Laboratory Medicine, Zunyi Medical University, Guizhou Province, Zunyi 563003, China;
2.School of Medicine, Guizhou University, Guizhou Province, Guiyang 550025, China;
3.Department of Medical Genetics, Guizhou Provincial People’s Hospital, Guizhou Province, Guiyang 550002, China
|
|
|
Abstract Objective To identify the β-globin gene sequence of suspected cases of β-thalassemia (“β-thalassemia” for short”), the rare mutation site identified and the clinical phenotype were analyzed. Methods From January 2020 to March 2022, 20 suspected β-thalassemia carriers with hematologic phenotype but no related β-thalassemia gene test results were negative in Guizhou Provincial People’s Hospital. The full length of β-globin gene was amplified by PCR, The amplification products were sequenced bidirectionally by Sanger sequencing technique. The sequencing results were compared with the β-globin gene reference sequence to find out whether there were rare mutations. Results Among 20 Carriers with suspected β-thalassaemia, 15 were found to carry rare β-globin gene mutations, with a total of six mutation types: CD53(-T), CD5(-CT), CD8(-AA), -88(C>A), Cap+22(G>A) and -50(G>A). Except for one case of -50(G>A) carrier, the other 14 cases showed the clinical phenotype of β-thalassaemia minor. Conclusion Rare β-globin gene analysis in suspected carriers whose phenotypes were not consistent with their genotypes plays an important role in guiding β-thalassemia genetic counseling, prenatal diagnosis and reducing the birth of children with moderate and severe β-thalassaemia. The results of this study broaden the mutation spectrum of β-globin gene in Chinese population and Guizhou region.
|
|
|
|
|
[1] Ali S,Mumtaz S,Shakir HA,et al. Current status of beta-thalassemia and its treatment strategies [J]. Mol Genet Genomic Med,2021,9(12):e1788.
[2] Jaing TH,Chang TY,Chen SH,et al. Molecular genetics of β-thalassemia:A narrative review [J]. Medicine (Baltimore), 2021,100(45):e27522.
[3] Zakaria NA,Bahar R,Abdullah WZ. Genetic Manipulation Strategies for β-Thalassemia:A Review [J]. Front Pediatr. 2022,10:901605.
[4] 刘畅.中国十省地区地中海贫血基因突变类型及血红蛋白A2截断值的研究[D].广州:广州医科大学,2019.
[5] 中华医学会医学遗传学分会遗传病临床实践指南撰写组,商璇,吴学东,等.β-地中海贫血的临床实践指南[J].中华医学遗传学杂志,2020,37(3):243-251.
[6] 中华医学会儿科学分会血液学组,《中华儿科杂志》编辑委员会.重型β-地贫的诊断和治疗指南(2017年版)[J].中华儿科杂志,2018,56(10):724-729.
[7] 杨塬,朱丽丹,张颖,等.重庆地区108140例疑似贫血患者地中海贫血筛查及检出基因型分析[J].第三军医大学学报,2020,42(17):1750-1756.
[8] 罗世强,严提珍,邓新娥,等.罕见α-地中海贫血分子鉴定及诊断方法的研究[Z].柳州市妇幼保健院,2021.
[9] 王柏莲,黄珍艳,李琼,等.1例由脐血血红蛋白电泳追溯到的罕见型新生儿β珠蛋白生成障碍性贫血基因家系分析[J].重庆医学,2021,50(19):3322-3325.
[10] 徐韫健,廖颖茵,高俊,等.广东地区地中海贫血筛检者的基因检测和类型分析[J].实用医学杂志,2019,35(2):285-289,293.
[11] 罗海艳,刘艳秋,谢康,等.江西地区24例罕见β-地中海贫血患者基因型分析[J].实验与检验医学,2020, 38(3):466-469.
[12] 庄建龙,张娜,王元白,等.中国福建泉州地区育龄夫妇地中海贫血基因分析及产前诊断[J].中国实验血液学杂志,2022,30(1):217-221.
[13] Yi P,Yu F,Huang S,et al. Identification of a novel frameshift mutation at codon 53(-T) in the beta-globin gene causing dominantly inherited beta-thalassemia in a Chinese Miao family [J]. Blood Cells Mol Dis,2008,41(1):56-59.
[14] 伊鹏.一种见于苗族家系的导致显性遗传性β-地贫的新移码突变的鉴定[D].广州:南方医科大学,2008.
[15] 刘兴梅,苏莉,李贵芳,等.贵州地区β-地中海贫血基因突变类型分析[J].中华医学遗传学杂志,2014,31(5):561-564.
[16] Kollia P,Gonzalez-Redondo JM,Stoming TA,et al. Frame- shift codon 5 [Fsc-5(-CT)] thalassemia;a novel mutation detected in a Greek patient [J]. Hemoglobin,1989,13(6): 597-604.
[17] 郭薇霞,唐健,何建萍,等.两例β-地中海贫血病例中罕见HBB基因突变的鉴定[J].国际检验医学杂志,2019, 40(12):1517-1520.
[18] Giardine B,Borg J,Viennas E. Updates of the HbVar dat- abase of human hemoglobin variants and thalassemia mutations [DB]. Nucleic Acids Res,2014,42(Database issue):D1063-9.
[19] 李厚钧,余伍忠,周常文,等.四例维吾尔族β地中海贫血CD8(-AA)突变型[J].中华医学遗传学杂志,1994, 11(3):136-138,193.
[20] El-Shanshory M,Hagag A,Shebl S,et al. Spectrum of Beta Globin Gene Mutations in Egyptian Children with β-Thalassemia [J]. Mediterr J Hematol Infect Dis,2014,6(1):e2014071.
[21] Origa R. Beta-Thalassemia [M]. 2000 Sep 28 [Updated 2021 Feb 4]. In:Adam MP,Everman DB,Mirzaa GM,et al. editors. GeneReviews? [Internet]. Seattle (WA):UniversityofWashington,Seattle1993-2022.Availablefrom:https://www.ncbi.nlm.nih.gov/books/NBK1426/.
[22] Cai SP,Eng B,Francombe WH,et al. Two novel beta-thalassemia mutations in the 5’ and 3’ noncoding regions of the beta-globin gene [J]. Blood,1992,79(5):1342-1346.
[23] Oner R,Agarwal S,Dimovski AJ,et al. The G——A mutation at position +22 3’ to the Cap site of the beta-globin gene as a possible cause for a beta-thalassemia [J]. Hemog- lobin,1991,15(1/2):67-76.
[24] Li DZ,Liao C,Xie XM,et al. A novel mutation of -50(G-->A) in the direct repeat element of the beta-globin gene identified in a patient with severe beta-thalassemia [J]. Ann Hematol,2009,88(11):1149-1150.
[25] Zhao Y,Jiang F,Li DZ,et al. Hematological Characteristics of β-Globin Gene Mutation -50(G>A)(HBB:c.-100G>A)Carriers in Mainland China [J]. Hemoglobin,2020,44(4):240-243.
|
|
|
|